Disease | leukemia |
Phenotype | C0019829|hodgkin lymphoma |
Sentences | 3 |
PubMedID- 23295809 | Risk of therapy-related secondary leukemia in hodgkin lymphoma: the stanford university experience over three generations of clinical trials. |
PubMedID- 22708037 | The risk of therapy-related myelodysplasia/acute myeloid leukemia in hodgkin lymphoma has substantially decreased in the abvd era abolishing mechlorethamine and procarbazine and limiting volumes and doses of radiotherapy. |
PubMedID- 23497375 | There is ample evidence linking notch and hematologic malignancies, including hodgkin and non-hodgkin lymphomas, subsets of acute myeloid leukemia, and b-cell chronic lymphoid leukemia [16-18]. |
Page: 1